Alkem Laboratories Ltd. header image

Alkem Laboratories Ltd.

539523

Equity

ISIN INE540L01014 / Valor 30689895

Bombay Stock Exchange Ltd. (Mumbai) (2026-07-03)
INR 5,570.70+1.36%

Alkem Laboratories Ltd.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Alkem Laboratories Ltd. is an Indian multinational pharmaceutical company headquartered in Mumbai and listed on the Indian stock exchanges that develops, manufactures and markets a broad range of prescription and over‑the‑counter medicines and active pharmaceutical ingredients (APIs). The business combines a large domestic branded‑generics franchise with international sales of generics and specialty products in regulated markets such as the United States and Europe as well as in emerging markets; its therapeutic portfolio spans anti‑infectives, gastroenterology, pain management, vitamins and minerals, antidiabetics, and cardiovascular treatments. Alkem also invests in formulation and process R&D and files regulatory dossiers (including ANDAs) to support its exports, while deriving revenue from manufacturing, licensing and contract services in addition to product sales.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

15.6%1Y
59.7%3Y
74.9%5Y

Performance

22.4%1Y
24.7%3Y
23.4%5Y

Volatility

Market cap

6981 M

Market cap (USD)

Daily traded volume (Shares)

17,927

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

IVF HARTMANN Holding AG
IVF HARTMANN Holding AG IVF HARTMANN Holding AG Valor: 18762425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 129.00
Xlife Sciences Ltd.
Xlife Sciences Ltd. Xlife Sciences Ltd. Valor: 46192960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 18.15
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd Cohance Lifesciences Ltd Valor: 46346459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.62%INR 454.85
Glaukos Corp
Glaukos Corp Glaukos Corp Valor: 28262610
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.83%USD 148.34
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.58%CHF 331.80
MedCap AB
MedCap AB MedCap AB Valor: 34063678
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.18%SEK 545.00
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.96%USD 76.42
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.97%CHF 11.96
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.20%CHF 125.10
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.65%CHF 108.35